For example, high ARHGAP5 expression is associated with aggressive behavior of non-small-cell lung carcinoma, while the non-coding RNA derived from ARHGAP5 can inhibit breast cancer migration22 and the circular RNA produced by ARHGAP5 can inhibit cisplatin resistance in cervical squamous-cell carcinoma7. This evidence concerns the gene ARHGAP5 and breast carcinoma.